Goldline Pharmac

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE1CLW01015
  • NSEID:
  • BSEID: 544759
INR
41.17
-0.07 (-0.17%)
BSENSE

Aug 11

BSE+NSE Vol: 105000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10040007,
    "name": "Goldline Pharmac",
    "stock_name": "Goldline Pharmac",
    "full_name": "Goldline Pharmaceutical Ltd",
    "name_url": "stocks-analysis/goldline-pharmac",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "41.17",
    "chg": -0.07,
    "chgp": "-0.17%",
    "dir": -1,
    "prev_price": "41.24",
    "mcapval": "39.52 Cr",
    "mcap": "",
    "scripcode": 544759,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE1CLW01015",
    "curr_date": "Aug 11",
    "curr_time": "",
    "bse_nse_vol": 105000,
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/goldline-pharmac-10040007-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "10040007",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/goldline-pharmaceutical-10040007"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "07-Aug-2026",
      "details": "Notice published by way of an advertisement in respect of 22nd Annual General Meeting (AGM) of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Record Date For Remote E-Voting",
      "datetime": "06-Aug-2026",
      "details": "Intimation of Record Date for remote e-voting",
      "source": "BSE"
    },
    {
      "caption": "Reg. 34 (1) Annual Report.",
      "datetime": "06-Aug-2026",
      "details": "Submission of Annual Report of Goldline Pharmaceutical Limited for FY 2025-26.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

07-Aug-2026 | Source : BSE

Notice published by way of an advertisement in respect of 22nd Annual General Meeting (AGM) of the Company.

Intimation Of Record Date For Remote E-Voting

06-Aug-2026 | Source : BSE

Intimation of Record Date for remote e-voting

Reg. 34 (1) Annual Report.

06-Aug-2026 | Source : BSE

Submission of Annual Report of Goldline Pharmaceutical Limited for FY 2025-26.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available